不整脈モニタリング装置市場レポート：2030年までの動向、予測、競合分析

不整脈モニタリング装置の動向と予測

世界の不整脈モニタリング装置市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定112億米ドルに達すると予測されます。この市場の主な促進要因は、心血管疾患の有病率の増加と、不整脈の早期発見と治療の重要性に対する意識の高まりです。世界の不整脈モニタリング装置市場の将来は、病院・診療所市場や診断センター市場にビジネスチャンスがあり、有望視されています。

不整脈モニタリング装置市場の洞察

Lucintelの予測では、ホルターモニターは、利便性、非侵襲性、正確性などの様々な特徴により、予測期間中に最も高い成長が見込まれています。

この市場の中では、必要なインフラ、医療知識、必要なリソースが利用可能であることから、これらの施設における不整脈モニタの需要が増加しているため、病院と診療所が最大のセグメントであり続けると思われます。

北米は、人口の間で脳卒中リスクが高まっていること、強固なヘルスケアインフラが存在すること、主要企業が存在することから、予測期間中に最も高い成長が見込まれます。

市場規模・推計：不整脈モニタリング装置の市場規模を金額（Bドル）で推計。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

セグメント別分析：不整脈モニタリング装置市場規模を用途別、最終用途別、地域別など様々なセグメント別に金額（億米ドル）で推計。

地域別分析：不整脈モニタリング装置市場の北米、欧州、アジア太平洋地域、その他世界の地域内訳。

成長機会：不整脈モニタリング装置市場の用途、最終用途、地域別の成長機会分析。

戦略分析：不整脈モニタリング装置市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の不整脈モニタリング装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界の不整脈モニタリング装置市場の動向（2018年～2023年）と予測（2024年～2030年）
• タイプ別の世界の不整脈モニタリング装置市場
  • ECGモニター
  • 埋め込み型モニター
  • ホルター心電図
  • モバイル心臓テレマトリー
  • その他
• 用途別の世界の不整脈モニタリング装置市場
  • 頻脈
  • 心房頻脈
  • 心室頻拍
  • 徐脈
  • 期外収縮
• 最終用途別の世界の不整脈モニタリング装置市場
  • 病院・クリニック
  • 診断センター
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の不整脈モニタリング装置市場
• 北米の不整脈モニタリング装置市場
• 欧州の不整脈モニタリング装置市場
• アジア太平洋の不整脈モニタリング装置市場
• その他の地域の不整脈モニタリング装置市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の不整脈モニタリング装置市場の成長機会
  • 用途別の世界の不整脈モニタリング装置市場の成長機会
  • エンドユース別の世界の不整脈モニタリング装置市場の成長機会
  • 地域別の世界の不整脈モニタリング装置市場の成長機会
• 世界の不整脈モニタリング装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の不整脈モニタリング装置市場の能力拡大
  • 世界の不整脈モニタリング装置市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott Laboratories
• GE Healthcare
• Koninklijke Philips
• Boston Scientific
• Medtronic
• Asahi Kasei
• Nihon Kohden

Cardiac Arrhythmia Monitoring Device Trends and Forecast

The future of the global cardiac arrhythmia monitoring device market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global cardiac arrhythmia monitoring device market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing prevalence of cardiovascular diseases and rising awareness of the importance of early detection and treatment of cardiac arrhythmias.

A more than 150-page report is developed to help in your business decisions.

Cardiac Arrhythmia Monitoring Device by Segment

The study includes a forecast for the global cardiac arrhythmia monitoring device by type, application, end use, and region.

Cardiac Arrhythmia Monitoring Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• ECG Monitors
• Implantable Monitors
• Holter Monitors
• Mobile Cardiac Telematory
• Others

Cardiac Arrhythmia Monitoring Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Tachycardiac
• Atrial Tachycardiac
• Ventricular Tachycardiac
• Bradycardiac
• Premature Contraction

Cardiac Arrhythmia Monitoring Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Cardiac Arrhythmia Monitoring Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cardiac Arrhythmia Monitoring Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac arrhythmia monitoring device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac arrhythmia monitoring device companies profiled in this report include-

• Abbott Laboratories
• GE Healthcare
• Koninklijke Philips
• Boston Scientific
• Medtronic
• Asahi Kasei
• Nihon Kohden

Cardiac Arrhythmia Monitoring Device Market Insights

Lucintel forecasts that holter monitor is expected to witness highest growth over the forecast period due to its various features, such as convenience, noninvasiveness, and accuracy.

Within this market, hospital and clinic will remain the largest segment due to growing demand for cardiac arrhythmia monitors in these facilities given to the availability of necessary infrastructure, medical knowledge, and resources needed.

North America is expected to witness highest growth over the forecast period due to growing risk of stroke among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global Cardiac Arrhythmia Monitoring Device Market

Market Size Estimates: Cardiac arrhythmia monitoring device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac arrhythmia monitoring device market size by various segments, such as by application, end use, and region in terms of value ($B).

Regional Analysis: Cardiac arrhythmia monitoring device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and regions for the cardiac arrhythmia monitoring device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac arrhythmia monitoring device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cardiac arrhythmia monitoring device market size?

Answer: The global cardiac arrhythmia monitoring device market is expected to reach an estimated $11.2 billion by 2030.

Q.2 What is the growth forecast for cardiac arrhythmia monitoring device market?

Answer: The global cardiac arrhythmia monitoring device market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cardiac arrhythmia monitoring device market?

Answer: The major drivers for this market are growing prevalence of cardiovascular diseases and rising awareness of the importance of early detection and treatment of cardiac arrhythmias.

Q4. What are the major segments for cardiac arrhythmia monitoring device market?

Answer: The future of the cardiac arrhythmia monitoring device market looks promising with opportunities in the hospital & clinic and diagnostic center markets.

Q5. Who are the key cardiac arrhythmia monitoring device market companies?

Answer: Some of the key cardiac arrhythmia monitoring device companies are as follows:

• Abbott Laboratories
• GE Healthcare
• Koninklijke Philips
• Boston Scientific
• Medtronic
• Asahi Kasei
• Nihon Kohden

Q6. Which cardiac arrhythmia monitoring device market segment will be the largest in future?

Answer: Lucintel forecasts that holter monitor is expected to witness highest growth over the forecast period due to its various features, such as convenience, noninvasiveness, and accuracy.

Q7. In cardiac arrhythmia monitoring device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing risk of stroke among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cardiac arrhythmia monitoring device market by type (ecg monitors, implantable monitors, and holter monitors, mobile cardiac telematory, others), application (tachycardiac, atrial tachycardiac, ventricular tachycardiac, bradycardiac, and premature contraction), end use (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Arrhythmia Monitoring Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cardiac Arrhythmia Monitoring Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cardiac Arrhythmia Monitoring Device Market by Type
  • 3.3.1: ECG Monitors
  • 3.3.2: Implantable Monitors
  • 3.3.3: Holter Monitors
  • 3.3.4: Mobile Cardiac Telematory
  • 3.3.5: Others
• 3.4: Global Cardiac Arrhythmia Monitoring Device Market by Application
  • 3.4.1: Tachycardiac
  • 3.4.2: Atrial Tachycardiac
  • 3.4.3: Ventricular Tachycardiac
  • 3.4.4: Bradycardiac
  • 3.4.5: Premature Contraction
• 3.5: Global Cardiac Arrhythmia Monitoring Device Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cardiac Arrhythmia Monitoring Device Market by Region
• 4.2: North American Cardiac Arrhythmia Monitoring Device Market
  • 4.2.2: North American Cardiac Arrhythmia Monitoring Device Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.3: European Cardiac Arrhythmia Monitoring Device Market
  • 4.3.1: European Cardiac Arrhythmia Monitoring Device Market by Type: ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others
  • 4.3.2: European Cardiac Arrhythmia Monitoring Device Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.4: APAC Cardiac Arrhythmia Monitoring Device Market
  • 4.4.1: APAC Cardiac Arrhythmia Monitoring Device Market by Type: ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others
  • 4.4.2: APAC Cardiac Arrhythmia Monitoring Device Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.5: ROW Cardiac Arrhythmia Monitoring Device Market
  • 4.5.1: ROW Cardiac Arrhythmia Monitoring Device Market by Type: ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telematory, and Others
  • 4.5.2: ROW Cardiac Arrhythmia Monitoring Device Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cardiac Arrhythmia Monitoring Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Cardiac Arrhythmia Monitoring Device Market by Application
  • 6.1.3: Growth Opportunities for the Global Cardiac Arrhythmia Monitoring Device Market by End Use
  • 6.1.4: Growth Opportunities for the Global Cardiac Arrhythmia Monitoring Device Market by Region
• 6.2: Emerging Trends in the Global Cardiac Arrhythmia Monitoring Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cardiac Arrhythmia Monitoring Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Arrhythmia Monitoring Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: GE Healthcare
• 7.3: Koninklijke Philips
• 7.4: Boston Scientific
• 7.5: Medtronic
• 7.6: Asahi Kasei
• 7.7: Nihon Kohden